 Shares of NextCure Inc NASDAQ:NXTC have received an average recommendation of Buy from the ten brokerages that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month target ... 